Lubris BioPharma Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

Lubris BioPharma General Information

Description

Developer of a human lubricin designed for the treatment of the dry eye. The company offers an endogenous complex glycoprotein that binds to and protects tissue surfaces from friction-induced wear and damage and helps in the treatment of surgical adhesions, xerostomia, pericarditis, and other conditions, enabling doctors to offer improved treatment for dry eye disease.

Contact Information

Website
www.lubris.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 85 Nobscot Road
  • Weston, MA 02493
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 85 Nobscot Road
  • Weston, MA 02493
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lubris BioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 15-Mar-2017 Completed Generating Revenue
5. Later Stage VC Completed Generating Revenue
4. Early Stage VC (Series A) 01-Jul-2015 Completed Generating Revenue
3. Accelerator/Incubator 22-Sep-2014 Completed Pre-Clinical Trials
2. Seed Round 15-Mar-2013 $4M $4M Completed Startup
1. University Spin-Out 01-Jan-2011 Completed Startup
To view Lubris BioPharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Lubris BioPharma Patents

  • 116

    Total Documents Applications and Grants

  • Total Patents Families

  • 88

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Lubris BioPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3976085-A4 Use of prg4 to treat cancer Inactive 03-Jun-2019
EP-3976085-A1 Use of prg4 to treat cancer Inactive 03-Jun-2019
US-20220332839-A1 Use of prg4 to treat cancer Inactive 03-Jun-2019
EP-3810181-A1 Lubricin for use in wound healing Inactive 21-Jun-2018
AU-2019290206-A1 Lubricin for use in wound healing Inactive 21-Jun-2018 A61K38/39
To view Lubris BioPharma’s complete patent history, request access »

Lubris BioPharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lubris BioPharma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tarnagulla Ventures Venture Capital Minority
CONNECT(San Diego) Accelerator/Incubator
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
University of Washington University
SeedFolio Venture Capital Minority
To view Lubris BioPharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Lubris BioPharma FAQs

  • When was Lubris BioPharma founded?

    Lubris BioPharma was founded in 2011.

  • Where is Lubris BioPharma headquartered?

    Lubris BioPharma is headquartered in Weston, MA.

  • What is the size of Lubris BioPharma?

    Lubris BioPharma has 4 total employees.

  • What industry is Lubris BioPharma in?

    Lubris BioPharma’s primary industry is Biotechnology.

  • Is Lubris BioPharma a private or public company?

    Lubris BioPharma is a Private company.

  • What is Lubris BioPharma’s current revenue?

    The current revenue for Lubris BioPharma is .

  • How much funding has Lubris BioPharma raised over time?

    Lubris BioPharma has raised $4M.

  • Who are Lubris BioPharma’s investors?

    Tarnagulla Ventures, CONNECT(San Diego), Johnson & Johnson Innovation - JLABS, University of Washington, and SeedFolio have invested in Lubris BioPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »